Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Vanda Loses US Trade Secrets Battle Over Fanapt And Hetlioz Generics
Jan 24 2025
•
By
Dean Rudge
The federal court said the dissolution specifications adopted by generics firms were not developed by Vanda. • Source: Shutterstock
More from Litigation
More from Legal & IP